(Q44533678)

English

Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

quality of life

1 reference

based on heuristic

inferred from title

author name string

Worrawat Chanpattana

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Barry Alan Kramer

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Schizophrenia Research

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

189-193

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Convulsive therapy in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Revising axis V for DSM-IV: a review of measures of social functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of ECT in the United States in 1975, 1980, and 1986.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0920-9964(02)00330-4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44533678&oldid=2079077587"